What has been reported in the available human pilot research is that no significant adverse effects were observed - which is a meaningful data point for safety consideration, even if it does not establish efficacy by clinical standards
Seasonal Adjustments : Learn to adapt your eating and supplement routine to seasonal changes, holidays, and life events while maintaining your progress
Stephen O'Rahilly - beneficios riesgos GLP1 Stephen O'Rahilly Profesor de Bioqumica Clnica y Medicina y director del Instituto Wellcome-MRC de Ciencia Metablica-Laboratorios de Investigacin Metablica de la Universidad de Cambridge (Reino Unido) Los estudios como este deben interpretarse con mucha cautela, ya que las personas estudiadas no han sido asignadas aleatoriamente al tratamiento con agonistas del receptor GLP-1, por lo que cualquier diferencia entre quienes toman y no toman esta clase de medicamentos podra ser atribuible a factores distintos al frmaco
The clinical results are genuinely impressive
Antihypertensive effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists
While originally developed to manage type 2 diabetes, brand-name versions like Wegovy and Zepbound are now fully FDA-approved for chronic weight management
